CHA Vaccine Research Institute (KOSDAQ:261780)
South Korea
· Delayed Price · Currency is KRW 2,880.00
-35.00 (-1.20%)
At close: Mar 21, 2025, 3:30 PM KST
KOSDAQ:261780 Revenue
In the year 2024, CHA Vaccine Research Institute had annual revenue of 370.66M KRW with 26.02% growth. CHA Vaccine Research Institute had revenue of -10.00 in the quarter ending December 31, 2024.
Revenue
370.66M
Revenue Growth
+26.02%
P/S Ratio
204.78
Revenue / Employee
n/a
Employees
n/a
Market Cap
75.65B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |